The role of T1 mapping and Extracellular Volume (ECV) in predicting cardiac reverse remodelling and response to Heart Failure with reduced Ejection Fraction (HFrEF) therapy

10 May 2023 (08:00 - 20:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Alice Zheng

Portsmouth Hospitals NHS Trust, Portsmouth (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail

The impact of BMI on myocardial work and left atrial strain in young overweight patients with preserved left ventricular ejection fraction

Doctor G. Trimarchi (Pisa, IT)

Abstract Slides

Presentation thumbnail

Symplified pulmonary ultrasound in heart failure patients with preserved systolic function

Professor M. Tsverava (Tbilisi, GE)

Abstract Slides

Presentation thumbnail

Baseline native T1 values are associated with adverse outcome in a newly diagnosed, hospitalised heart failure patient population

Doctor A. Zheng (Portsmouth, GB)

Abstract Slides

Presentation thumbnail

Acute effects of interruption of cardiac resynchronization therapy on left ventricular morpho-functional parameters as assessed by cardiac magnetic resonance

Doctor C. Basile (Stockholm, SE)

Abstract Slides

Presentation thumbnail

Sex-specific impairment of cardiac functional reserve in HFpEF: insights from the HFpEF-Stress trial

Mr A. Schulz (Boston, US)

Abstract Slides

Access the full session

Session thumbnail

Heart Failure 2

The Event

Event poster

EACVI 2023

10 May - 12 May 2023

You may be interested in

Congress Presentation

Cardiac magnetic resonance imaging in the work-up and management of cardiac amyloidosis

Congress Presentation

CMR for inflammation, oedema, and the pericardium

Congress Presentation

Impact of extracellular volume fraction on reverse remodeling and outcomes in non-ischemic cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources